GB9806513D0 - Membrane-bound receptors - Google Patents

Membrane-bound receptors

Info

Publication number
GB9806513D0
GB9806513D0 GBGB9806513.9A GB9806513A GB9806513D0 GB 9806513 D0 GB9806513 D0 GB 9806513D0 GB 9806513 A GB9806513 A GB 9806513A GB 9806513 D0 GB9806513 D0 GB 9806513D0
Authority
GB
United Kingdom
Prior art keywords
membrane
bound receptors
receptors
bound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9806513.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phytopharm Ltd
Original Assignee
Phytopharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytopharm Ltd filed Critical Phytopharm Ltd
Priority to GBGB9806513.9A priority Critical patent/GB9806513D0/en
Publication of GB9806513D0 publication Critical patent/GB9806513D0/en
Priority to AU31574/99A priority patent/AU748138B2/en
Priority to GB9907100A priority patent/GB2335599B/en
Priority to IDW20002147A priority patent/ID26781A/en
Priority to CNB2005100529656A priority patent/CN100377714C/en
Priority to NZ507355A priority patent/NZ507355A/en
Priority to RU2000126789/14A priority patent/RU2242978C2/en
Priority to CA002325634A priority patent/CA2325634A1/en
Priority to PL99343423A priority patent/PL195897B1/en
Priority to HU0103654A priority patent/HUP0103654A2/en
Priority to AU31581/99A priority patent/AU3158199A/en
Priority to PCT/GB1999/000951 priority patent/WO1999048507A2/en
Priority to BR9909109-7A priority patent/BR9909109A/en
Priority to DE69943415T priority patent/DE69943415D1/en
Priority to CNB998061581A priority patent/CN1198622C/en
Priority to ES99913453T priority patent/ES2272060T3/en
Priority to KR1020097000085A priority patent/KR101092050B1/en
Priority to MXPA00009437A priority patent/MXPA00009437A/en
Priority to DE69929177T priority patent/DE69929177T2/en
Priority to PL380866A priority patent/PL207723B1/en
Priority to KR1020077027370A priority patent/KR20070117001A/en
Priority to AT99913453T priority patent/ATE337788T1/en
Priority to KR1020007010677A priority patent/KR100632052B1/en
Priority to JP2000537532A priority patent/JP2003524581A/en
Priority to KR1020067027786A priority patent/KR20070007214A/en
Priority to JP2000537555A priority patent/JP3768100B2/en
Priority to PL99343508A priority patent/PL343508A1/en
Priority to PT99913453T priority patent/PT1066042E/en
Priority to DE69933016T priority patent/DE69933016T2/en
Priority to TR2000/02774T priority patent/TR200002774T2/en
Priority to AT06017380T priority patent/ATE507834T1/en
Priority to PCT/GB1999/000960 priority patent/WO1999048482A2/en
Priority to CA002325633A priority patent/CA2325633C/en
Priority to HU0101693A priority patent/HUP0101693A3/en
Priority to DK06017380.4T priority patent/DK1719512T3/en
Priority to ES99913462T priority patent/ES2257042T3/en
Priority to IL13866399A priority patent/IL138663A0/en
Priority to EP06017380A priority patent/EP1719512B1/en
Priority to IDW20002146A priority patent/ID26989A/en
Priority to EP99913453A priority patent/EP1066042B1/en
Priority to CNB998060429A priority patent/CN1209112C/en
Priority to KR1020007010698A priority patent/KR100713311B1/en
Priority to BR9909110-0A priority patent/BR9909110A/en
Priority to IL13866499A priority patent/IL138664A0/en
Priority to EP99913462A priority patent/EP1066033B1/en
Priority to KR1020097000581A priority patent/KR20090009997A/en
Priority to TR2000/02773T priority patent/TR200002773T2/en
Priority to AT99913462T priority patent/ATE314057T1/en
Priority to DK99913453T priority patent/DK1066042T3/en
Priority to IL138663A priority patent/IL138663A/en
Priority to IS5637A priority patent/IS5637A/en
Priority to IS5638A priority patent/IS5638A/en
Priority to HR20000638A priority patent/HRP20000638A2/en
Priority to HR20000637A priority patent/HRP20000637A2/en
Priority to NO20004804A priority patent/NO20004804L/en
Priority to NO20004803A priority patent/NO20004803L/en
Priority to ZA200006047A priority patent/ZA200006047B/en
Priority to ZA200006046A priority patent/ZA200006046B/en
Priority to HK01104289A priority patent/HK1033742A1/en
Priority to HK01104373A priority patent/HK1033903A1/en
Priority to US10/077,493 priority patent/US6812213B2/en
Priority to US10/336,176 priority patent/US20030118673A1/en
Priority to JP2004073541A priority patent/JP2004217666A/en
Priority to JP2004073546A priority patent/JP2004224797A/en
Priority to US10/894,425 priority patent/US20060182817A1/en
Priority to RU2004123463/15A priority patent/RU2297228C2/en
Priority to IL174991A priority patent/IL174991A0/en
Priority to US11/502,784 priority patent/US7507720B2/en
Priority to CY20061101448T priority patent/CY1105653T1/en
Priority to HK06112803.6A priority patent/HK1091417A1/en
Priority to NO20083993A priority patent/NO20083993L/en
Priority to NO20085251A priority patent/NO20085251L/en
Ceased legal-status Critical Current

Links

GBGB9806513.9A 1998-03-26 1998-03-26 Membrane-bound receptors Ceased GB9806513D0 (en)

Priority Applications (72)

Application Number Priority Date Filing Date Title
GBGB9806513.9A GB9806513D0 (en) 1998-03-26 1998-03-26 Membrane-bound receptors
AU31574/99A AU748138B2 (en) 1998-03-26 1999-03-26 Steroidal sapogenins and their derivatives for treating alzheimers disease
GB9907100A GB2335599B (en) 1998-03-26 1999-03-26 Membrane-bound receptors and their function; cognitive disfunction; treatments therefor; and compositions for use in such treatments
IDW20002147A ID26781A (en) 1998-03-26 1999-03-26 SAPOGENIN STEROID AND ITS DECLARATION TO TREAT ALZHEIMER DISEASE
CNB2005100529656A CN100377714C (en) 1998-03-26 1999-03-26 Steroidal sapogenins and their derivatives for treating alzheimer's disease
NZ507355A NZ507355A (en) 1998-03-26 1999-03-26 Membrane-bound receptors and their function; cognitive disfunction; treatments therefor; and compositions for use in such treatments
RU2000126789/14A RU2242978C2 (en) 1998-03-26 1999-03-26 Steroid sapogenin and their derivatives for treatment of alzheimer's disease
CA002325634A CA2325634A1 (en) 1998-03-26 1999-03-26 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
PL99343423A PL195897B1 (en) 1998-03-26 1999-03-26 Membrane-bound receptors and their function; cognitive disfunction; treatments therefor; and compositions for use in such treatments
HU0103654A HUP0103654A2 (en) 1998-03-26 1999-03-26 Use of smilagenin and anzurogenin-d for production of pharmaceutical compositions for the treatment of alzheimer's disease
AU31581/99A AU3158199A (en) 1998-03-26 1999-03-26 Smilagenin and anzurogenin-d and their use
PCT/GB1999/000951 WO1999048507A2 (en) 1998-03-26 1999-03-26 Steroidal saponins for treating alzheimer's disease
BR9909109-7A BR9909109A (en) 1998-03-26 1999-03-26 Uses of one or more among smilagenin, pleasedigenin, an astragaloside, tigogenin, ruscogenin, hecogenin, diogenin, smilagenin, anzurogenin d or an astragaloside and an extract from a plant of the genus smilax, asparagus, anemarrhena, yucca, yucca or yucca. for the treatment of a condition distinguished by a deficiency in the function or the number of membrane-bound postsynaptic receptors, pharmaceutical composition, and, processes to enhance cognitive function in a human or non-human animal and in a patient suffering from an age-related cognitive impairment, and to treat a condition distinguished by a deficiency in function or the number of membrane-bound receptors in a tissue, organ, cell type or organelle
DE69943415T DE69943415D1 (en) 1998-03-26 1999-03-26 Sarsasapogenin and smilagenin for the treatment of cognitive disorders
CNB998061581A CN1198622C (en) 1998-03-26 1999-03-26 Steroidal saponins for treating alzheimer's disease
ES99913453T ES2272060T3 (en) 1998-03-26 1999-03-26 RECEIVERS UNITED MEMBRANE AND ITS FUNCTION; COGNITIVE DYSFUNCTION; TREATMENTS FOR THE SAME; AND COMPOSITIONS FOR USE IN THESE TREATMENTS.
KR1020097000085A KR101092050B1 (en) 1998-03-26 1999-03-26 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
MXPA00009437A MXPA00009437A (en) 1998-03-26 1999-03-26 Smilagenin and anzurogenin-d and their use.
DE69929177T DE69929177T2 (en) 1998-03-26 1999-03-26 SMILAGENINE AND ANZUROGENIN-D FOR THE TREATMENT OF ALZHEIMER'S DISEASE
PL380866A PL207723B1 (en) 1998-03-26 1999-03-26 Steroid sapogenins and their derivatives intended for treating Alzheimer disease
KR1020077027370A KR20070117001A (en) 1998-03-26 1999-03-26 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
AT99913453T ATE337788T1 (en) 1998-03-26 1999-03-26 STEROIDAL SAPONINS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
KR1020007010677A KR100632052B1 (en) 1998-03-26 1999-03-26 Steroidal sapogenins and their derivatives for treating alzheimer's disease
JP2000537532A JP2003524581A (en) 1998-03-26 1999-03-26 Smilagenin and anzlogenin-D for the treatment of Alzheimer's disease
KR1020067027786A KR20070007214A (en) 1998-03-26 1999-03-26 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
JP2000537555A JP3768100B2 (en) 1998-03-26 1999-03-26 Steroid sapogenins and their derivatives for the treatment of Alzheimer's disease
PL99343508A PL343508A1 (en) 1998-03-26 1999-03-26 Smilagenin and anzurogenin-d and their use
PT99913453T PT1066042E (en) 1998-03-26 1999-03-26 Steroidal saponins for treating alzheimer`s disease
DE69933016T DE69933016T2 (en) 1998-03-26 1999-03-26 STEROIDAL SAPONINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
TR2000/02774T TR200002774T2 (en) 1998-03-26 1999-03-26 Steroid sapogenes and their derivatives for the treatment of Alzheimer's disease
AT06017380T ATE507834T1 (en) 1998-03-26 1999-03-26 SARSASAPOGENIN AND SMILAGENIN FOR THE TREATMENT OF COGNITIVE DISORDERS
PCT/GB1999/000960 WO1999048482A2 (en) 1998-03-26 1999-03-26 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
CA002325633A CA2325633C (en) 1998-03-26 1999-03-26 Steroidal sapogenins and their derivatives for treating alzheimer's disease
HU0101693A HUP0101693A3 (en) 1998-03-26 1999-03-26 Use of steroidal sapogenins and their derivatives for producing pharmaceutical compositions for the treatment of alzheimeirs disease
DK06017380.4T DK1719512T3 (en) 1998-03-26 1999-03-26 Sarsasapogenin and smilagenin for the treatment of cognitive dysfunction
ES99913462T ES2257042T3 (en) 1998-03-26 1999-03-26 ESMILAGENINA AND ANZUROGENINA-D FOR THE TREATMENT OF ALZHEIMER'S DISEASE.
IL13866399A IL138663A0 (en) 1998-03-26 1999-03-26 Steroidal sapogenins and their derivatives for treating alzheimer's disease
EP06017380A EP1719512B1 (en) 1998-03-26 1999-03-26 Sarsasapogenin and smilagenin for treating cognitive dysfunctions
IDW20002146A ID26989A (en) 1998-03-26 1999-03-26 SMILAGENIN AND ANZUROGENIN-D FOR TREATMENT OF ALZHEIMER
EP99913453A EP1066042B1 (en) 1998-03-26 1999-03-26 Steroidal saponins for treating alzheimer's disease
CNB998060429A CN1209112C (en) 1998-03-26 1999-03-26 Smilagenin and anzurogenin-D for curing Alzheimer's disease
KR1020007010698A KR100713311B1 (en) 1998-03-26 1999-03-26 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
BR9909110-0A BR9909110A (en) 1998-03-26 1999-03-26 Uses of smilagenin and anzurogenin d, pharmaceutical composition having cognitive function enhancing properties, process to intensify cognitive function, and composition for use thereof
IL13866499A IL138664A0 (en) 1998-03-26 1999-03-26 Smilagenin and anzurogenin-d for the treatment of alheimer's disease
EP99913462A EP1066033B1 (en) 1998-03-26 1999-03-26 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
KR1020097000581A KR20090009997A (en) 1998-03-26 1999-03-26 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
TR2000/02773T TR200002773T2 (en) 1998-03-26 1999-03-26 Smilagen and anzurogenin-D and their use for the treatment of Alzheimer's.
AT99913462T ATE314057T1 (en) 1998-03-26 1999-03-26 SMILAGENIN AND ANZROGENIN-D FOR THE TREATMENT OF ALZHEIMER'S DISEASE
DK99913453T DK1066042T3 (en) 1998-03-26 1999-03-26 Steroidal saponins for the treatment of Alzheimer's disease
IL138663A IL138663A (en) 1998-03-26 2000-09-24 Steroidal sapogenins and their derivatives for treating alzheimer's disease
IS5637A IS5637A (en) 1998-03-26 2000-09-25 Steroid sapogenins and their derivatives for the treatment of Alzheimer's disease
IS5638A IS5638A (en) 1998-03-26 2000-09-25 Smylagenin and anzurogenin-D for the treatment of Alzheimer's disease
HR20000638A HRP20000638A2 (en) 1998-03-26 2000-09-26 Steroidal sapogenins and their derivatives for treating alzheimer's disease
HR20000637A HRP20000637A2 (en) 1998-03-26 2000-09-26 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
NO20004804A NO20004804L (en) 1998-03-26 2000-09-26 Steroid sapogenes and their derivatives for the treatment of Alzheimer's disease
NO20004803A NO20004803L (en) 1998-03-26 2000-09-26 Smilagening and anzurogenin for the treatment of Alzheimer's disease
ZA200006047A ZA200006047B (en) 1998-03-26 2000-10-26 Smilagenin and anzurogenin-D for the treatment of Alzheimer's disease.
ZA200006046A ZA200006046B (en) 1998-03-26 2000-10-26 Steroidal sapogenins and their derivatives for treating Alzheimer's disease.
HK01104289A HK1033742A1 (en) 1998-03-26 2001-06-20 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
HK01104373A HK1033903A1 (en) 1998-03-26 2001-06-22 Steroidal saponins for treating alzheimer's disease
US10/077,493 US6812213B2 (en) 1998-03-26 2002-02-15 Steroidal sapogenins and their derivatives for treating alzheimer's disease
US10/336,176 US20030118673A1 (en) 1998-03-26 2003-01-03 Smilagenin and anzurogenin-D for the treatment of alzheimer's disease
JP2004073541A JP2004217666A (en) 1998-03-26 2004-03-15 Steroid sapogenin and its derivative for treating alzheimer's disease
JP2004073546A JP2004224797A (en) 1998-03-26 2004-03-15 Steroid sapogenin and its derivative for treating alzheimer's disease
US10/894,425 US20060182817A1 (en) 1998-03-26 2004-07-17 Steroidal sapogenins and their derivatives for treating Alzheimer's disease
RU2004123463/15A RU2297228C2 (en) 1998-03-26 2004-07-29 Steroid sapogenins and their derivatives usable in medical treatment
IL174991A IL174991A0 (en) 1998-03-26 2006-04-11 Steroidal sapogenins and their derivatives for treating alzheimer's disease
US11/502,784 US7507720B2 (en) 1998-03-26 2006-08-11 5-Beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia
CY20061101448T CY1105653T1 (en) 1998-03-26 2006-10-10 Steroidal saponins for the treatment of ALZHEIMER'S DISEASE
HK06112803.6A HK1091417A1 (en) 1998-03-26 2006-11-22 Sarsasapogenin and smilagenin for treating cognitive dysfunctions
NO20083993A NO20083993L (en) 1998-03-26 2008-09-19 Use of sarsasapogenin and smilagenin in the preparation of medications
NO20085251A NO20085251L (en) 1998-03-26 2008-12-16 Steroid sapogenes and their derivatives for the treatment of Alzheimer's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9806513.9A GB9806513D0 (en) 1998-03-26 1998-03-26 Membrane-bound receptors

Publications (1)

Publication Number Publication Date
GB9806513D0 true GB9806513D0 (en) 1998-05-27

Family

ID=10829328

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9806513.9A Ceased GB9806513D0 (en) 1998-03-26 1998-03-26 Membrane-bound receptors

Country Status (3)

Country Link
GB (1) GB9806513D0 (en)
RU (1) RU2242978C2 (en)
ZA (2) ZA200006047B (en)

Also Published As

Publication number Publication date
RU2242978C2 (en) 2004-12-27
ZA200006047B (en) 2002-01-28
ZA200006046B (en) 2002-01-28

Similar Documents

Publication Publication Date Title
GB9818719D0 (en) Vubration exciter
DE59912562D1 (en) Indolyl-3-glyoxylsäure-derivate mit antitumorwirkung
PL345247A1 (en) Retinoid-associated receptor regulators
DE69924297D1 (en) Orthopädische prothese mit zementkompressionsring
GB9826359D0 (en) Novel receptors
HUP0101753A3 (en) Boring-tool
EP0994900A4 (en) Semaphorin receptors
EP1084142A4 (en) Gpr35a receptor
GB9816729D0 (en) Substituted cyclohexylaminopyrimidines
HK1039937A1 (en) Substituted 3-thiocarbamoylpyrazoles
PL347397A1 (en) Substituted 3-aryl-pyrazoles
GB9818915D0 (en) Antibodies
EP1039903A4 (en) Il-8 receptor antagonists
EP1047424A4 (en) Il-8 receptor antagonists
EP1120426A4 (en) Novel g protein-coupled receptors
EP1079848A4 (en) Angiostatin receptor
GB9819420D0 (en) Novel receptor
AU3543599A (en) Receptors
HUP0102476A3 (en) Substituted cyclooctadepsipeptides
HK1039335A1 (en) Substituted benzoylcyclohexandiones
EP1083909A4 (en) hCEPR RECEPTOR
EP1131335A4 (en) 7tm receptor hlwar77
IL137327A0 (en) Orphan receptors
GB9806513D0 (en) Membrane-bound receptors
GB9819411D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)